Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isodiol International Inc ISOLF

Isodiol International Inc is a manufacturer and developer of phytoceutical consumer products using pharmaceutical and nutraceutical grade phytochemical compounds. It generates revenue from the sale of nutritional health products derived from hemp. Geographically, it derives a majority of revenue from the United States and also has a presence in Canada. Its product categories include Tinctures; Capsules; Topicals; Vape; Oral Spray; Skincare; and others.


GREY:ISOLF - Post by User

Bullboard Posts
Post by Zebullon Mar 30, 2018 9:19am
96 Views
Post# 27807598

President - BSPG

President - BSPG

Michael Stephenson is the president of BSPG - HK



  • President CEO


    BioSynthesis Pharma Group Limited
     – Present (6 years 1 month)Hong Kong

    As President and CEO at BIOSYNTHESIS PHARMA GROUP (BSPG) we specializes in the resource of industrial hemp derivatives for innovative medicinal formulations in the pharmaceutical, nutraceutical and cosmetic markets. Their major focus is the development of CBD production for the benefit of those suffering from a range of serious, life threatening diseases, such as cancer, neurodegenerative and autoimmune diseases. Neuropsychiatric disorders and symptomatic, non-life threatening conditions like skin care and skin disease therapies are additional benefits achieved by CBD. The culmination of these efforts focus on forging key relationships with institutions and government agencies that have developed the world’s most advanced CBD production technologies. BSPG has obtained the exclusive rights to technology and production capacity that cannot be found anywhere else in the world, and is currently the largest global industrial source of CBD worldwide. Due to their operation being situated in close proximity to hemp fields and employing skilled human resources, BSPG is able to optimize large scale CBD production at cost effective operating costs, including adequate quality control systems as GAPC and GMP.

Bullboard Posts